Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of Tadalafil (Cialis or Adcirca) added with Levofloxacin to treat patients with Chronic Prostatitis, also known as chronic pelvic pain syndrome

Trial Profile

A study of Tadalafil (Cialis or Adcirca) added with Levofloxacin to treat patients with Chronic Prostatitis, also known as chronic pelvic pain syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 30 May 2018

At a glance

  • Drugs Tadalafil (Primary) ; Levofloxacin
  • Indications Prostatitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 May 2018 New trial record
    • 20 May 2018 According to an American Urological Association media release, data from this study will be presented at the 113th Annual Scientific Meeting of the American Urological Association (AUA).
    • 20 May 2018 Results presented in an American Urological Association media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top